key: cord-0814870-jw6r23wi
authors: Gao, Jinzhi; Hu, Xiaolin; Sun, Xuan; Luo, Xiaoping; Chen, Ling
title: Possible intrauterine infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth
date: 2020-08-06
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.07.063
sha: 2a14299c860c8d5c4d52a3f7ceeb05f1a18e55d7
doc_id: 814870
cord_uid: jw6r23wi

Whether SARS-CoV-2 affects fetus in utero is important to the well-being of mother and neonate. We report a full-term neonate born to the mother who developed symptoms of COVID-19 at 32-week gestational age. The placental pathology showed local slight inflammation. Serial quantitative antibody measurements in the neonate showed the level of IgM was elevated at the day of birth and gradually declined to negative within 28 days of life, the levels of IgG declined gradually but still positive at 50th day of life. The dynamic change trend of antibody levels in the neonate was consistent with that in his mother. One-step Reverse Transcriptase-droplet digital Polymerase Chain Reaction for SARS-CoV-2 nucleic acid testing from throat and anal swabs showed positive results (750 and 892 copies/ml) at 7th day of life and negative results at 14th day of life. The neonate had no symptom of COVID-19. This report enables us to reevaluate the significance of IgM detection in intrauterine infection of SARS-CoV-2, and presents a favorable prognosis in the neonate with long-term exposure to maternal COVID-19, despite great possibility of intrauterine infection.

Pregnancy with COVID-19 disease is a special scenario that needs a good understanding of the pathophysiology of this disease (Sahu et al., 2020) . In particular, whether SARS-CoV-2 affects fetus in utero. Neonates are susceptible to SARS-CoV-2 infection, and vertical transmission is possible (Alzamora et al., 2020) . Evidence has shown that SARS-CoV-2 nucleic acid testing result was positive in blood sample and the fetal surface of placenta (Baud et al., 2020 . However, previous reports showed no evidence of SARS-CoV-2 genome in amniotic fluid or umbilical cord blood, as well as no detection in samples of newborns immediately after birth . Minimal symptoms were observed in neonates when their mothers delivery timely after the onset of COVID-19 in the third trimester (Alzamora et al., 2020 , Zhu et al., 2020 . We report a full-term neonate born to the mother who developed symptoms of COVID-19 at 32-week gestational age and underwent elective cesarean section at 38-week gestational age due to previous Cesarean section.

The mother was far from due date when infected and chose to continue the pregnancy to full term, which might cause the fetus to be long-term exposure to inflammatory factors and/or viremia. The affection of maternal COVID-19 on fetus was evaluated by placental pathology, nucleic acid testing, sequential specific SARS-CoV-2 antibody titers and clinical features within 50 days after birth.

for SARS-CoV-2 nucleic acid testing was performed with throat swabs and placenta of the mother, and feces, throat and anal swabs of the neonate from 0 th to 14 th day of life. The detail of the method was described in previous report (Liu et al., 2020) . At 7 th and 14 th day of life, One-step Reverse Transcriptase-droplet digital Polymerase Chain Reaction (One-step RT-ddPCR) (QX200 droplet generator and QX200 droplet reader (BioRad, USA)) was used to detect nucleic acid of throat and anal swabs in the neonate. The copies > 50 copies/ml were considered as positive. Detailed method of J o u r n a l P r e -p r o o f One-step RT-ddPCR is provided in the Supplementary Appendix.

Quantitative assessment of IgG and IgM was performed using chemiluminescence immunoassay (IFlash3000 Chemiluminescence Immunoassay Analyzer and chemiluminescence immunoassay kits, YHLO Biotech Co., Ltd, Shenzhen China), which has been proved to be a highly accurate method to detect the anti-SARS-CoV-2 antibodies profile (Infantino et al., 2020) . The titers > 10 AU/ml were considered as positive. Placenta was fixed and then stained by Hematoxylin Eosin staining to get its pathological analysis. The timeline of symptom onset, serological testing and nucleic acid testing is detailed in Figure 1A .

The mother was a medical staff in our hospital, with a history of close contact with COVID-19 patients. She was 30 years old (G2P1), and developed the symptoms of COVID-19 at 32-week gestational age. Seven days later, she was confirmed as COVID-19 by positive nucleic acid tesingt result. She underwent elective cesarean section at 38-week gestational age due to previous Cesarean section. IgM and IgG titers were high on the day of delivery, while the nucleic acid testing result was negative ( Figure 1B ).

The male neonate had a birth weight of 2700g. The Apgar scores (1min-5min) were 8 and 9. The amniotic fluid and umbilical cord were normal. There was no symptom of COVID-19, though the blurred lung CT images showed a few small speckle in bilateral lungs ( Figure F ). As followed up to 50 th day of life, all healthy index was normal.

The placental pathology showed local slight fibrin deposition and lymphocyte infiltrates ( Figure 1G H) . Several repetitive RT-PCR for SARS-CoV-2 nucleic acid testing results from placenta, amniotic fluid, throat and anal swabs of the neonate from 0 th to 14 th day of life all showed negative. But One-step RT-ddPCR performed with throat and anal swabs showed positive (750 and 892 copies/ml) at 7 th day of life, J o u r n a l P r e -p r o o f while RT-PCR still showed negative at the same time ( Figure 1A ). In fact, the sensibility of One-step RT-ddPCR is much higher than that of RT-PCR for virus nucleic acid testing (Pinheiro-de-Oliveira et al., 2019). But One-step RT-ddPCR technology was not ready for detection SARS-CoV-2 in the early stage of the pandemic until 7 th of day of life in the neonate.

Serial quantitative antibody measurements showed the level of IgM was elevated at the day of birth and gradually declined to negative within 28 days of life, the level of IgG declined gradually but maintained at a high level from 0 th to 50 th day of life. The dynamic change trend of IgM and IgG levels was consistent with that of his mother.

Meanwhile, when the result of One-step RT-ddPCR showed positive at 7 th day of life, antibody titers still showed tendency of decreasing, which ruled out infection after birth (Figure 1 B) .

In adult, serological testing has been used as a complementary tool in COVID-19 diagnostics. Both of IgM and IgG appeared around 13 days post disease onset. Plateau IgM levels lasted for at least 4 weeks and gradually declined, and IgG antibody lasted for a longer time (Long et al., 2020) . Since maternal IgM is not penetrable to the placenta due to its large size, the detection of unequivocal IgM in neonates suggests intrauterine infection. Studies have tried to diagnose intrauterine infection of SARS-CoV-2 by elevated specific IgM titers in 3 neonates after birth (Dong et al., 2020 , Zeng H et al., 2020 , but researchers cast doubt on the potential for false-positive IgM (Kimberlin et al., 2020) . In our report, the consecutive positive SARS-CoV-2-specific IgM and the consistency of the dynamic change trend of antibody levels between the neonate and his mother confirmed the accuracy of the antibody testing results, which ruled out the potential for false-positive. The levels of IgM and IgG in COVID-19 dyads declined gradually over time from the day of birth, which might suggest that both of the COVID-19 dyads were not at acute phase of J o u r n a l P r e -p r o o f infection after partum.

Although no evidence supports intrauterine infection in SARS and MERS, there is evidence supporting intrauterine infection of other coronavirus (Schwartz et al., 2020) .

Virological findings in the placenta supported placental infection of SARS-CoV-2, but no intrauterine infection in the fetus maybe due to short-term exposure to maternal COVID-19 (Baud et al., 2020) 

Severe COVID-19 during pregnancy and possible vertical transmission

Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn

Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience

Can SARS-CoV-2 infection be acquired in utero?: More definitive evidence is needed

Detection of Covid-19 in children in early

Reverse transcriptase droplet digital PCR to identify the emerging vesicular virus Senecavirus A in biological samples

Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections

Detection of SARS-CoV-2 in different types of clinical specimens

Antibodies in infants born to mothers with COVID-19 pneumonia

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan

The authors declare no conflicts of interest.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.